Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Tallarida

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Life Sciences|January 1, 1996
Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologramR J Tallarida, R B Raffa
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1977
Further studies on the action of ultraviolet light on vascular smooth muscle: effect of partial irreversible receptor blockadeL S Jacob, R J Tallarida
Journal of Pharmacological Methods|March 1, 1991
Determination of the functional dissociation constant of a partial agonist by comparison with a higher efficacy agonistK A Freeman, R J Tallarida
Life Sciences|January 1, 1991
Control and stability of ligand receptor interaction in the presence of a competitive compoundR J Tallarida, K A Freeman
Life Sciences|January 1, 1989
Statistical analysis of drug-drug and site-site interactions with isobologramsR J Tallarida, F Porreca, A Cowan
European Journal of Pharmacology|April 25, 1990
Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interactionF Porreca, Q Jiang, R J Tallarida
European Journal of Pharmacology|November 19, 1981
Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the ratF Porreca, A Cowan, R J Tallarida
European Journal of Pharmacology|August 17, 1984
An evaluation of tamoxifen as a partial agonist by classical receptor theory--an explanation of the dual action of tamoxifenM W MacNab, R J Tallarida, R Joseph
Life Sciences|January 1, 1996
Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonistsA Mao, K A Freeman, R J Tallarida
Clinical Pharmacology and Therapeutics|April 1, 1979
A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and riskR J Tallarida, R B Murray, C Eiben
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Life Sciences|January 1, 1996
Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologramR J Tallarida, R B Raffa
Archives Internationales De Pharmacodynamie Et De Therapie|January 1, 1977
Further studies on the action of ultraviolet light on vascular smooth muscle: effect of partial irreversible receptor blockadeL S Jacob, R J Tallarida
Journal of Pharmacological Methods|March 1, 1991
Determination of the functional dissociation constant of a partial agonist by comparison with a higher efficacy agonistK A Freeman, R J Tallarida
Life Sciences|January 1, 1991
Control and stability of ligand receptor interaction in the presence of a competitive compoundR J Tallarida, K A Freeman
Life Sciences|January 1, 1989
Statistical analysis of drug-drug and site-site interactions with isobologramsR J Tallarida, F Porreca, A Cowan
European Journal of Pharmacology|April 25, 1990
Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interactionF Porreca, Q Jiang, R J Tallarida
European Journal of Pharmacology|November 19, 1981
Time course of antagonism of morphine antinociception by intracerebroventricularly administered naloxone in the ratF Porreca, A Cowan, R J Tallarida
European Journal of Pharmacology|August 17, 1984
An evaluation of tamoxifen as a partial agonist by classical receptor theory--an explanation of the dual action of tamoxifenM W MacNab, R J Tallarida, R Joseph
Life Sciences|January 1, 1996
Transient loss of dopamine autoreceptor control in the presence of highly potent dopamine agonistsA Mao, K A Freeman, R J Tallarida
Clinical Pharmacology and Therapeutics|April 1, 1979
A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and riskR J Tallarida, R B Murray, C Eiben
Pageof 8